Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.

The American journal of surgical pathology - 1 Nov 2020

Shah Abhishek, Lal Priti, Toorens Erik, Palmer Matthew B, Schwartz Lauren, Vergara Norge, Guzzo Thomas, Nayak Anupma

Abstract excerpt

Individuals with acquired cystic kidney disease (ACKD) in the setting of end-stage renal disease (ESRD) have a high risk of developing renal cell carcinoma (RCC). ACKD-RCC is considered a distinct renal neoplasm in the International Society of Urologic Pathologists (ISUP)-World Health Organization (WHO) classification of kidney tumors which may behave aggressively. Since its original description, there have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to DNA-Binding Proteins

Share to Kidney Diseases, Cystic

Share to Kidney Failure, Chronic

Share to Kidney Neoplasms

Share to Tuberous Sclerosis Complex 2 Protein

Source

Identifiers

PMID: 32604168
DOI: 10.1097/PAS.0000000000001530

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.PMID 32604168Read ↗

Implication of KMT2C and TSC2 variants in the tumorigenesis of acquired cystic disease-associated renal cell carcinomas.Semantic proximity Read ↗

Advancing the molecular understanding of renal tumorigenesis: Acquired cystic disease-associated renal cell carcinoma (ACD-RCC) as a model system.Semantic proximity Read ↗

Acquired cystic disease associated renal cell carcinoma: A clinicopathologic and molecular study of 31 tumors.Semantic proximity Read ↗

Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB/TFE3 pathway.Semantic proximity Read ↗

Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.Semantic proximity Read ↗

Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.Semantic proximity Read ↗

Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategiesSemantic proximity Read ↗

Integrated clinicopathological, genomic, and immunophenotypic landscape of renal tubulocystic oncocytoma.Semantic proximity Read ↗

Adult Renal Cell Carcinoma: A Review of Established Entities from Morphology to Molecular Genetics.Semantic proximity Read ↗

Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features.Semantic proximity Read ↗

Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-upSemantic proximity Read ↗

ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.